Answer
Nivolumab is not recommended during pregnancy unless clinical benefit outweighs potential risk; human pregnancy data are absent, animal studies show embryofoetal toxicity, and placental transmission is possible.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 70Document updated
Sources checked